IL22 and obesity due to melanocortin 4 receptor deficiency: In the current study, we analyzed the effects of endogenous IL-22 and chronic treatment with rmIL-22 as well as genetic overexpression of IL-22 on HFD-induced obesity and metabolic syndrome.